Skip to main content
BCYC logo
BCYC
(NASDAQ)
Bicycle Therapeutics plc
$4.15-- (--)
Loading... - Market loading

Bicycle Therapeutics (BCYC) Stock Price & Financial Analysis

Bicycle Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.95 - $4.24
52-Week High$9.18
52-Week Low$3.97
Open$4.10
Volume2.98M
Average Volume (3M)349.37K
Market Cap282.22M
Shares Outstanding69.68M
Price to Sales (P/S)4.42
Price to Book (P/B)0.51
EV/EBITDA1.25
Revenue (TTM)63.50M
Net Income (TTM)-219.03M
Free Cash Flow (TTM)-229.01M
EPS (TTM)$-3.16
Profit Margin-344.95%
Operating Margin-383.18%
Return on Equity (ROE)-39.51%
Debt to Equity0.03
50-Day MA$4.71
200-Day MA$6.18
52-Week Change-53.20%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Bicycle Therapeutics

What is the current stock price for BCYC?

As of the latest trading session, BCYC stock trades at $4.15. The 52-week range is $3.97–$9.18, with a day range of $3.95–$4.24.

What is the P/E ratio for BCYC?

The P/E ratio (Price-to-Earnings) for BCYC is shown in the Key Statistics section. This valuation metric helps compare Bicycle Therapeutics plc to industry peers.

Does BCYC pay dividends?

Bicycle Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BCYC?

Based on 7 analysts, the consensus for BCYC is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BCYC?

Bicycle Therapeutics's market capitalization is $289.2M, classifying it as a micro-cap company..